{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T17:11:51Z","timestamp":1769793111060,"version":"3.49.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,29]]},"DOI":"10.7759\/cureus.102600","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:03:03Z","timestamp":1769742183000},"source":"Crossref","is-referenced-by-count":0,"title":["COVID-19-Associated Acquired Hemophilia A With an Exceptionally High Inhibitor Titer: A Case of Remission and Overwhelming Sepsis"],"prefix":"10.7759","author":[{"given":"Shaivya","family":"Pathak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"Tiede A","year":"2020","unstructured":"Tiede A, Collins P, Knoebl P, et al.. International recommendations on the diagnosis and treatment of acquired hemophilia A. Haematologica. 2020, 105:1791-801. 10.3324\/haematol.2019.230771","journal-title":"Haematologica"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl P","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F, et al.. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012, 10:622-31. 10.1111\/j.1538-7836.2012.04654.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850","article-title":"Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation","volume":"109","author":"Collins PW","year":"2007","unstructured":"Collins PW, Hirsch S, Baglin TP, et al.. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. Blood. 2007, 109:1870-7. 10.1182\/blood-2006-06-029850","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25865","article-title":"The first case of acquired hemophilia A associated with SARS-CoV-2 infection","volume":"95","author":"Franchini M","year":"2020","unstructured":"Franchini M, Glingani C, De Donno G, et al.. The first case of acquired hemophilia A associated with SARS-CoV-2 infection. Am J Hematol. 2020, 95:E197-8. 10.1002\/ajh.25865","journal-title":"Am J Hematol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/trf.16254","article-title":"De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection","volume":"61","author":"Olsen GM","year":"2021","unstructured":"Olsen GM, Rinder HM, Tormey CA. De novo acquired hemophilia as an immune dysregulation phenomenon following SARS-CoV-2 infection. Transfusion. 2021, 61:989-91. 10.1111\/trf.16254","journal-title":"Transfusion"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jth.15291","article-title":"A case report of acquired hemophilia following COVID-19 vaccine","volume":"19","author":"Radwi M","year":"2021","unstructured":"Radwi M, Farsi S. A case report of acquired hemophilia following COVID-19 vaccine. J Thromb Haemost. 2021, 19:1515-8. 10.1111\/jth.15291","journal-title":"J Thromb Haemost"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.21909","article-title":"Acquired hemophilia A post-COVID-19 vaccination: a case report and review","volume":"14","author":"Al Hennawi H","year":"2022","unstructured":"Al Hennawi H, Al Masri MK, Bakir M, et al.. Acquired hemophilia A post-COVID-19 vaccination: a case report and review. Cureus. 2022, 14:e21909. 10.7759\/cureus.21909","journal-title":"Cureus"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins P","year":"2012","unstructured":"Collins P, Baudo F, Knoebl P, et al.. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012, 120:47-55. 10.1182\/blood-2012-02-409185","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"Baudo F","year":"2012","unstructured":"Baudo F, Collins P, Huth-K\u00fchne A, et al.. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012, 120:39-46. 10.1182\/blood-2012-02-408930","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14740\/jmc3827","article-title":"Acquired hemophilia A developed post COVID-19 vaccine: an extremely rare complication","volume":"13","author":"Soliman DS","year":"2022","unstructured":"Soliman DS, Al Battah A, Al Faridi D, Ibrahim F. Acquired hemophilia A developed post COVID-19 vaccine: an extremely rare complication. J Med Cases. 2022, 13:1-4. 10.14740\/jmc3827","journal-title":"J Med Cases"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.20467","article-title":"Immunosuppression therapy in acquired hemophilia A: pursuing an optimal regimen","volume":"13","author":"Teixeira Passos D","year":"2021","unstructured":"Teixeira Passos D, Abrantes AM, Santos L, Cardoso A, Pais de Lacerda A. Immunosuppression therapy in acquired hemophilia A: pursuing an optimal regimen. Cureus. 2021, 13:e20467. 10.7759\/cureus.20467","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/10760296241298661","article-title":"Outcomes of emicizumab in acquired hemophilia patients: a systematic review","volume":"30","author":"Ikbel G","year":"2024","unstructured":"Ikbel G, Hela B, Yassine KM, Hamida K, Kamel BS. Outcomes of emicizumab in acquired hemophilia patients: a systematic review. Clin Appl Thromb Hemost. 2024, 30:10760296241298661. 10.1177\/10760296241298661","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(23)00280-6","article-title":"Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study","volume":"10","author":"Tiede A","year":"2023","unstructured":"Tiede A, Hart C, Kn\u00f6bl P, et al.. Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study. Lancet Haematol. 2023, 10:e913-21. 10.1016\/S2352-3026(23)00280-6","journal-title":"Lancet Haematol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2024.06.010","article-title":"Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A","volume":"22","author":"Hart C","year":"2024","unstructured":"Hart C, Klamroth R, Sachs UJ, et al.. Emicizumab versus immunosuppressive therapy for the management of acquired hemophilia A. J Thromb Haemost. 2024, 22:2692-701. 10.1016\/j.jtha.2024.06.010","journal-title":"J Thromb Haemost"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26018","article-title":"2021 clinical trials update: innovations in hemophilia therapy","volume":"96","author":"Croteau SE","year":"2021","unstructured":"Croteau SE, Wang M, Wheeler AP. 2021 clinical trials update: innovations in hemophilia therapy. Am J Hematol. 2021, 96:128-44. 10.1002\/ajh.26018","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.084","article-title":"Skin color in dermatology textbooks: an updated evaluation and analysis","volume":"84","author":"Adelekun A","year":"2021","unstructured":"Adelekun A, Onyekaba G, Lipoff JB. Skin color in dermatology textbooks: an updated evaluation and analysis. J Am Acad Dermatol. 2021, 84:194-6. 10.1016\/j.jaad.2020.04.084","journal-title":"J Am Acad Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.12.078","article-title":"Medical students' ability to diagnose common dermatologic conditions in skin of color","volume":"83","author":"Fenton A","year":"2020","unstructured":"Fenton A, Elliott E, Shahbandi A, et al.. Medical students' ability to diagnose common dermatologic conditions in skin of color. J Am Acad Dermatol. 2020, 83:957-8. 10.1016\/j.jaad.2019.12.078","journal-title":"J Am Acad Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/458370-covid-19-associated-acquired-hemophilia-a-with-an-exceptionally-high-inhibitor-titer-a-case-of-remission-and-overwhelming-sepsis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:03:10Z","timestamp":1769742190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/458370-covid-19-associated-acquired-hemophilia-a-with-an-exceptionally-high-inhibitor-titer-a-case-of-remission-and-overwhelming-sepsis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,29]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.102600","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,29]]}}}